Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic.Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups.Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted.Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and “lockdown” measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic.Design: Cross-sectional survey.Setting: Worldwide.Participants: Starting on April 4, 2020 during a 5-week period, the survey received 185 responses from 77 countries.Measurements: To assess addiction medicine professionals' perceived changes in drug and alcohol supply, price, use pattern, and related complications during the COVID-19 pandemic.Findings: Participants reported (among who answered “decreased” or “increased”) a decrease in drug supply (69.0%) and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported, while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall.Conclusions: The global report on changes in the availability, use patterns, and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to people with SUD.
Background Drought is one of the most important environmental stresses that can adversely influence soil properties, plant growth, and productivity of agricultural crops including eggplant as an important vegetable crop. In recent years, the use of agricultural wastes has been reported as a beneficial and sustainable measure in soil water retention and fertility enhancement. In this study, the effect of date palm and pistachio biochar, vermicompost and a combination of biochar and vermicompost was evaluated on eggplant growth, yield and water use efficiency under deficit irrigation. Materials and methods The experiment was done in a split-split plot based on randomized complete block design with three replications and under open field conditions. The main plot was deficit irrigation in three levels of 100, 75 and 50% of plant water requirement (PWR), and the sub-plots were vermicompost in two levels of 0, 1500 g m−2, and biochar in three levels of 0, 500 g m−2 of the pistachio biochar and 500 g m−2 of the date palm biochar. Results The results showed that soil amendment with vermicompost and pistachio biochar and 100% PWR showed the best plant growth and performance. The early crop yield was highest under pistachio biochar and 50% PWR, while the total plant yield was highest under combined application of vermicompost and pistachio biochar at 100% PWR. The plant water use efficiency was maximum under mixed application of vermicompost and pistachio biochar at 50% PWR. Application of both pistachio biochar and vermicompost at 100% PWR resulted in the highest leaf concentrations of nitrogen, phosphorus, potassium, iron and manganese. The highest levels of physiologically important stress metabolites, including malondialdehyde, guaiacol peroxidase, superoxide dismutase and catalase enzymes were found in treatments without amendments or only with vermicompost and 50% PWR. Conclusion The results indicate that under normal and particularly water deficit conditions, vermicompost and biochar increased eggplant vegetative growth, yield and water use efficiency.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.